Pitch 3-6 :An-E-platform to Leverage Indian Healthcare Resources for Clinical Trial and Medical Documentation Ecosystem

[Summary]

Reseapro as an organization started its operation in 2009 with an ePlatform for research community to facilitate scientific journal publication in international journals with medical and non-medical as two of its verticals. With growth of medical vertical at Reseapro, it started ReseaproPharma in 2017 to facilitate regulatory writing, submission and post marketing service for pharmaceutical industry. While providing service in the pharma industry, team at Reseapro found a problem to solve in the Pharmaceutical value chain.

India consist of 17% of global population with 20% of total diseases is very suitable for the clinical trials but there are various challenges clinical trials industry is facing like data authentication, Real-time data sharing is also an issue in many places along with multi-site and multi-language clinical trials.

This has led to the emergence of a new digital ePlatform by ReseaproPharma, for aggregating healthcare resources for clinical trials and medical documentation system and solve the challenges faced by the industry. ePlatform plans to bring individuals like doctors, nurses, pharmacists, technicians and Organizations like Hospitals, clinical trial sites, EDC-IRT vendors, CROs and all the stake holders of the healthcare industry at one platform from all over the India. The ePlatform will be integrated by biometric identification named Aadhar where more than 1.17 billion people already been enrolled. This enables the production of authentic data of the patients that can lead to easy recruitment of patients in many places in India. Once we receive the real-time data, clinical trials can be conducted successfully with less turn around time to bring latest drugs and related products to market

ePlatform looks forward to potential partners, collaborators and investors who can take this idea to a new level, thus, benefitting the Pharmaceutical and Medical eco-system to bring latest drugs, medical equipment, diagnostic tools to market quickly and most cost-effective way.

[Mentors' comments]

　"Are there any tax incentives for international companies that wish to do clinical trials in India?"Dr. Laura Holberger, BioLabs

[Profile]

Mr. Mohapatra is a Co-Founder of Reseapro Scientific Services and Reseapro Pharma. He is a serial entrepreneur and strategic business developer with strong background in orchestrating the development and management of start-ups and offering advisory services for strategic partnerships between Indian and international companies. He is a Bachelor of Engineering in Information Technology and Global Master of Business Administration (Global Comparative Management) from Doshisha University, Kyoto, Japan